Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.1800 (-0.35%) ($40.1600 - $40.1800) on Fri. Dec. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 80 | Latest Price | $40.1800(-0.35%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 6.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(53%) IWO(49%) IWM(47%) IWC(44%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.295% in a week (0% probabilities). VIXM(-27%) UUP(-12%) VXX(-9%) TBT(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.22(-0.1%) | 10 Day Moving Average | $39.73(1.13%) | 20 Day Moving Average | $36.99(8.62%) | To recent high | -1.3% | To recent low | 26.3% | Market Cap | $5.491b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |